Health

Samsung Biologics Names John Rim as President and CEO

INCHEON, South Korea, Dec. 16, 2020 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) announcedJohn Rim as its President and CEO. The appointment was made effective immediately and formalized via the company's board of directors meeting today.

2020-12-16 20:00 1993

Chargebee and Eagle Eye partner to offer subscription services to help retail and hospitality companies drive recurring revenue

SAN FRANCISCO, Dec. 15, 2020 /PRNewswire/ -- Chargebee, the leading subscription billing and revenue management platform, today announced its partnership withEagle Eye Solutions (Eagle Eye), a SaaS-based provider enabling one-to-one performance marketing, to help retai...

2020-12-15 22:29 1718

Clarity Pharmaceuticals closes $25m capital raising

SYDNEY, Dec. 15, 2020 /PRNewswire/ -- Clarity Pharmaceuticals, a clinical stage radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce that it has completed a capital raising of$25,000,410. Dr Alan Taylor, Executive Chairman of Clarity Pharmaceuticals, co...

2020-12-15 22:12 2477

Appian Selected by Accenture as a Core Partner in the INTIENT Network for Life Sciences

Appian brings low-code speed and automation power to help drive innovation in drug discovery and scientific research MCLEAN, Va., Dec. 15, 2020 /PRNewswire/ -- Appian (NASDAQ: APPN) today announced that it has joined Accenture's INTIENT partner ecosystem as a core partner. The ecosystem is desig...

2020-12-15 22:00 4294

Singlera Genomics raises $150 million in Series B financing to promote the development and commercialization of early cancer screening products

SAN DIEGO and SHANGHAI, Dec. 15, 2020 /PRNewswire/ -- Singlera Genomics Inc. today announced that it raised$150 million in Series B financing. This round of financing was led by the CICC Kai Tak Innovative Biomedicine Fund, and co-led by Detong Capital and Furong Investment. The new group of inve...

2020-12-15 22:00 1782

GMAX Zhengzhou Manufacturing Site Breaks Ground

HANGZHOU, China, Dec. 15, 2020 /PRNewswire/ -- Gmax Biopharm today holds ground-breaking ceremony for itsZhengzhou, China manufacturing site which is the production base for its GMA102 (T2D), GMA105 (obesity), and GMA301A/B (PAH for adult and children) drugs to be launched between 2023-2025, upon...

2020-12-15 18:00 1520

Ruben S. Martin III Elected Chairman Of Mercy Ships International's Board Of Directors

Highly Accomplished Business Leader and Philanthropist has been a Long-Time Board Member and Supporter of Mercy Ships and its Work to Bring Hope and Healing to the World's Most Disadvantaged Peoples GARDEN VALLEY, Texas, Dec. 14, 2020 /PRNewswire/ -- Mercy Ships, the global healthcare charity th...

2020-12-14 23:00 3763

Mercy Ships Announces Retirement Of Board Chairman Myron Ullman, Who Has Been Instrumental In Achieving Its Mission Of Bringing Hope And Healing To The World's Most Disadvantaged Peoples

Since he became Chairman in 2001, Mercy Ships has seen exceptional growth including reaching the milestone of performing more than 100,000 surgical procedures on board its charity hospital ships, attracting 20,000 volunteers from 60 nations, and providing healthcare services and materials worth m...

2020-12-14 23:00 1637

Sunshine Guojian Selects Verseau's VSIG4-targeted Antibody as the Second Partnered Macrophage Checkpoint Modulator in Immuno-Oncology Collaboration

SHANGHAI, Dec. 14, 2020 /PRNewswire/ -- 3SBio Inc. ("3SBio")'s subsidiary, Sunshine Guojian Pharmaceutical (Shanghai) Co. Ltd. ("Sunshine Guojian") and Verseau Therapeutics, Inc.  ("Verseau") today announced the selection of a monoclonal antibody targeting VSIG4, as a ...

2020-12-14 22:28 2284

I-Mab Added to Nasdaq Biotechnology Index

SHANGHAI and GAITHERSBURG, Md., Dec. 14, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that I-Mab's American Depositary Shares (ADS) have been ...

2020-12-14 21:00 9270

TCEB Leveraging MICE Personnel to Support Government's Special Arrangement for the Entry of Overseas Investors

BANGKOK, Dec. 14, 2020 /PRNewswire/ -- Thailand Convention and Exhibition Bureau (TCEB), in collaboration with Department of Disease Control, has launched the specialised training for Destination Management Company (DMC) to design health-compliant itineraries as part of a government's special ar...

2020-12-14 14:29 2336

Senhwa Biosciences's Positive Topline Cholangiocarcinoma Data Abstract Accepted by 2021 ASCO Gastrointestinal Cancers Symposium

TAIPEI and SAN DIEGO, Dec. 13, 2020 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a clinical-stage biopharmaceutical company focused on next generation DNA Damage Response (DDR) therapeutics for the treatment of cancer , announced their Abstract on Cholangiocarcinoma treatment with Silmit...

2020-12-14 10:09 1998

Seegene's aggregated sales surpass KRW 1 tril. this year and plans on expanding annual production capacity to KRW 5 tril. in 2021

SEOUL, South Korea, Dec. 13, 2020 /PRNewswire/ -- South Korea's biotechnology company specializing in molecular diagnosis, Seegene Inc. (KQ096530), announced Monday that its aggregated sales this year have already surpassed theKRW 1 trillion mark, up nearly 10 times its previous annual sales of K...

2020-12-14 07:30 5048
1 ... 309310311312313